LVS vs ZVRA · P/E 28, rev $6.74B vs P/E 6.3, rev $75.9M
Las Vegas Sands Corp (LVS) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the LVS and ZVRA stock pages for the full models.
Not investment advice.